These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 26458725)

  • 1. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
    Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
    Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orphan nuclear receptor Nur77 inhibits low shear stress-induced carotid artery remodeling in mice.
    Yu Y; Cai Z; Cui M; Nie P; Sun Z; Sun S; Chu S; Wang X; Hu L; Yi J; Shen L; He B
    Int J Mol Med; 2015 Dec; 36(6):1547-55. PubMed ID: 26498924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Rho-kinase inhibition on artery wall mass and remodeling.
    Pearce JD; Li J; Edwards MS; English WP; Geary RL
    J Vasc Surg; 2004 Jan; 39(1):223-8. PubMed ID: 14718843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Sun XZ; Tian XY; Wang DW; Li J
    Eur Rev Med Pharmacol Sci; 2014; 18(7):959-64. PubMed ID: 24763873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
    Greig FH; Hutchison L; Spickett CM; Kennedy S
    Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.
    Raja SG
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):100-4. PubMed ID: 22670803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
    FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
    Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
    Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
    Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
    Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model.
    Schumacher D; Liehn EA; Nilcham P; Mayan DC; Rattanasopa C; Anand K; Crespo-Avilan GE; Hernandez-Resendiz S; Singaraja RR; Cook SA; Hausenloy DJ
    Sci Rep; 2021 Oct; 11(1):20674. PubMed ID: 34667238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
    Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of TGF-β signaling in smooth muscle cell prevents flow-induced vascular remodeling.
    Gao F; Chambon P; Tellides G; Kong W; Zhang X; Li W
    Biochem Biophys Res Commun; 2014 Nov; 454(1):245-50. PubMed ID: 25451249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.